Issuer disclosure record

$SUPN

Company name unavailable

Transactions involving this ticker in readable 2023 House reports. This page describes disclosure activity, not the issuer’s performance and not a recommendation to trade.

Purchases

Sales

Filers

Reports

Transaction history

Who disclosed trading $SUPN?

Open in trade feed →

Partial saleRep. Josh GottheimerNJ-05

$SUPNSupernus Pharmaceuticals, Inc. (SUPN)

Rep. Josh Gottheimer's filing reports that a joint account partially sold · $1,001 – $15,000

View transaction source status →

Traded Dec 23, 2022Notified Jan 4, 2023Filed Jan 13, 202321 days to file

Owner: JointOriginal filing ↗